Mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient on the prescription label.
New York Assembly Bill A10083 amends the education law to allow mifepristone or misoprostol to be dispensed without the name and address of the dispenser and patient on the prescription label. Instead, the name or address of the dispensing health care practice can be included. The bill requires that such information be recorded and maintained by the pharmacist. This change aims to protect patient privacy while ensuring that necessary records are kept for potential criminal investigations.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.